ACTA ENDOCRINOLOGICA (BUC)

The International Journal of Romanian Society of Endocrinology / Registered in 1938

in Web of Science Master Journal List

Acta Endocrinologica(Bucharest) is live in PubMed Central

Journal Impact Factor - click here.

Year Volume Issue First page
10.4183/aeb.
Author
Title
Abstract/Title
From through

  • Notes & Comments

    Haulica I, Bild W, Popescu R

    New facets of the renin-angiotensis system

    Acta Endo (Buc) 2007 3(2): 225-234 doi: 10.4183/aeb.2007.225

  • Case Report

    Karahisar Sirali S, Kavraz Tomar O, Buberci R, Bal AZ, Duranay M

    Parathyroid Adenoma Mimicking Tuberculosis in a Peritoneal Dialysis Patient

    Acta Endo (Buc) 2022 18(2): 225-227 doi: 10.4183/aeb.2022.225

    Abstract
    The most common cause of hypercalcemia is parathyroid hyperplasia and carcinoma. Tuberculosis(TB) and sarcoidosis are the most common granulomatous diseases of the parathyroid. We report a case of parathyroid adenoma that can mimic many lesions. A 46-year-old woman on continuous ambulatory peritoneal dialysis (CAPD) with symptoms and signs of hypercalcemia. Laboratory findings were consistent with tertiary hyperparathyroidism. She underwent elective parathyroidectomy due to high PTH values despite effective treatment including calcimimetics and vitamin D receptor activators. Subtotal thyroidectomy and three and a half of parathyroid adenomas were removed. Histopathological examination revealed features of parathyroid adenoma with granulomatosis infection that supports tuberculosis. In order to confirm the pathological findings, the PCR study was performed on the pathology specimens. After obtaining a negative result, the treatment was stopped. We have reported a case of parathyroid adenoma that mimicking tuberculosis.
  • Case Report

    Coculescu M, Poiana N, Raducanu-Lichiardopol C, Ionescu M

    Gonadoblastoma in a patient with 46XY gonadal dysgenesis

    Acta Endo (Buc) 2006 2(2): 227-238 doi: 10.4183/aeb.2006.227

    Abstract
    We present a 18 year old phenotypic female patient who presented for primary amenorrhea. Pelvic ultrasound revealed a hypoplastic uterus and CT scan showed a hypoplastic right gonad and a left gonadal tumor with extrapelvic location. Karyotype was 46XY. Hormonal assessment indicated hypergonadotropic hypogonadism: FSH was 39.69 mUI/ml, estradiol was 28.07 pg/ml, testosterone was 0.17 ng/ml. DHEA level was high – 21 ng/ml. Gonadectomy was performed at 15 years and histologic examination diagnosed left gonadoblastoma and right teratoma in a dysgenetic gonad. The patient had a good postoperatory evolution. Menses were induced with estrogenic and then estroprogestogenic treatment. Plastic breast surgery was performed at 18 years. Establishing the genotypic sex in patients with primary amenorrhea represents a crucial step knowing that intersex disorders bearing Y chromosomal material have a high risk for gonadoblastoma and germ cell tumors.
  • Endocrine Care

    Bãcanu EV, Lixandru D, Serafinceanu C

    The Association between Adipokines, Insulin Resistance Markers and Microalbuminuria in Obese Type 2 Diabetic Patients

    Acta Endo (Buc) 2014 10(2): 228-237 doi: 10.4183/aeb.2014.228

    Abstract
    Background. Adipose tissue is linked to cardiovascular and metabolic complications of diabetes by increased local production of adipokines that may lead to oxidative stress and endothelial dysfunction. Objective. The aim of the present study was to investigate the association between plasma adipokines levels and anthropometric and systemic endothelial dysfunction markers in obese type 2 diabetic patients. Materials and methods. Two groups of type 2 diabetic patients were selected considering their Body Mass Index (BMI) value: group 1, overweight (BMI= 28.4 -29.9 kg/m2; n = 35) and group 2, obese (≥30 BMI≤ 40 kg/m2; n = 45). In all patients there were assessed: height, weight, waist and hip circumference, visceral fat index, albumin/creatinine ratio (ACR), plasma levels of insulin, proinsulin, adiponectin and leptin. The HOMA-IR and waist to hip ratio (WHR)were calculated as well. Results. Comparing the obese diabetic patients with the overweight ones, plasma levels of leptin were higher (p<0.001) while adiponectin levels were lower (p<0.05). BMI was positively correlated with leptin (r=0.661, p<0.001) and negatively with adiponectin (r=-0.338, p=0.008). Moreover, leptin was positively correlated with the waist circumference (r=0.453, p<0.001), visceral fat index (r=0.555, p<0.001) and HOMA-IR (r=0.370, p=0.004) while adiponectin was negatively correlated with waist circumference (r=-0.350, p=0.006), visceral fat index (r=-0.269, p=0.038) and HOMA-IR (r=-0.318, p=0.013). We have also found positive correlation for ACR with HbA1c (r=0.549, p<0.001), glycemia (r=-0.411, p=0.001), HOMA-IR (r=0.445, p<0.001) and with leptin (r=0.276, p=0.033) and negative correlation with HDL-cholesterol (r=-0.304, p=0.018). Conclusions. Leptin and adiponectin, as indicators of chronic low grade inflammatory syndrome are involved in the pathogenesis of insulin resistance and endothelial dysfunction in obese type 2 diabetic patients.
  • Case Report

    Dyrmishi B, Olldashi T, Rista E, Fureraj T, Ylli D, Ylli A

    Severe Hypokalemia Induced Rhabdomyolysis by Primary Hyperaldosteronism Coexistent with Recurrent Bilateral Renal Calculi

    Acta Endo (Buc) 2017 13(2): 228-231 doi: 10.4183/aeb.2017.228

    Abstract
    Primary Hyperaldosteronism is one of the causes of secondary hypertension. Primary Hyperaldosteronism is characterised by an increase in the production of aldosterone and the inhibition of the secretion of renin. We described here a case with rhabdomyolysis and severe hypokalemia as a cause of primary hyperaldosteronism. The creatine kinase, aldosterone were very high. Cortisol values and midnight salivary cortisol values were within normal range. The patient had been under treatment for high blood pressure for more than six years, with ARBs and calcium channel blockers. During this time the potassium values measured frequently every year were below normal range, but primary hyperaldosteronism was not suspected.
  • Case Report

    Dinu Draganescu D, Militaru M, Trifa A

    A Case of 46,XX Testicular Disorder of Sex Development: Clinical, Molecular and Cytogenetic Studies

    Acta Endo (Buc) 2015 11(2): 233-239 doi: 10.4183/aeb.2015.233

    Abstract
    Aim. To investigate the cause of infertility in an azoospermic man and to describe the phenotype of a new 46,XX male case. Case report. We present the case of an infertile man, 33 years old, with a history of several years of infertility, diagnosed with the 46,XX male syndrome, SRY positive. The patient was diagnosed by clinical, hormonal, ultrasound and genetic criteria. Our patient was born at 39 weeks of pregnancy, from unrelated parents. The mother’s age was 22 years old and father’s age was 23 years old at the time of the conception. Both of his parents were exposed to chemical noxae before his conception. The case we report is a SRY positive 46,XX male with complete masculinization, confirmed by FISH and molecular analyses, caused by an X/Y chromosome inter-change during paternal meiosis. Conclusions. In our case, the SRY translocation, could probably be related to the paternal exposure to external factors like chemical noxae, but more data are necessary. Cytogenetic and molecular analyses are necessary for an accurate diagnosis, as well as endocrine testing and pelvis ultrasound.
  • Notes & Comments

    Haulica I, Bild W, Boisteanu D

    New challenges and perspectives in physiology. From the classical concept of homeostasis to physiome

    Acta Endo (Buc) 2005 1(2): 233-239 doi: 10.4183/aeb.2005.233

    References
    1. Cannon WB. The Wisdom of the Body, Norton Comp. Inc. New York, 1932.
    2. Lauralee Sherwood. Human physiology. Fourth edition. Brooks/Cole, Thomson Learning, Australia, Canada, U.S.A., 2001.
    3. Selye H. Annual Report on Stress. Acta Inc, Medical Publ, 1951.
    4. Watson JD, Crick FHC. Molecular structure of nucleic acids structure, 1953: 171, 737.
    5. Levin B. Genes. vol. V. Oxford University Press, 1994: 1091-1100.
    6. James P. Proteome Research: Mass Spectrometry, Springer, 2001.
    7. Barr M. Super models. Physiol Genomics 2003; 13:15-24.
    8. Ottoson D, Bartzai T, Hokfelt T, Fuxe K. Challenges and perspectives in neuroscience. Pergamon, U.S.A., U.K., Japan, 1995.
    9. Losel RM, Falkenstein E, Feuring M., Schultz A., Tillmann HC, Rossol-Haseroth K, Wehling M. Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev 2003; 83:965-1016.
    10. Wentherall JD. Gene therapy in perspective. Nature 1991; 349: 275-276. [CrossRef]
    11. Phillips M J and Gyurco R. Antisense oligonucleotides. New tools for physiology. News in Physiol. Sci 1997; 12: 99-105.
    12. Kamp RM, Kyriakidis D, Choli-Papadopoulu A. Proteome and protein analysis, Springer, 2000: 372.
    13. Wilkins MR, Williams KL, Appel RD. Proteome Research. New frontiers in Functional Genomics, Springer, 1997:243.
    14. Winslow RL, Boguski MS. Genome Informatics: Current Status and Future Prospects. Circulation Research 2003; 92:953-961. [CrossRef]
    15. Bassingthwaithe JB. A view of physiome. Conference Reports, Internat Congress Physiol Sci, St.Petersburg, 1997, LO63,11.
    16. Dzau V. Physiological genomics . The Physiologist 1997; 40(5): 205-209.
    17. Noble D. The Physiome Project in Understanding the Heart: the Cardiome. In: The Physiome Project, London, 1998.
    18. Haulica I, Rusu V, Bild W. Role of molecular biology in the progress of medical sciences. Rom. J. Physiol 1998; 35:1-2, 3-12.
    19. Haulica I. From molecular genetics to functional genomics in physiome. J. Cell. Mol. Med 2002; 6(4): 648- 653. [CrossRef]
    20. Swynghedauw B, Mausier P. Physiologie, Une science qui se reveille. Medecine/ Sciences 1999; 15: 868-872.
  • Editorial

    Grigorie D, Sucaliuc A

    Prevention of Falls and Fractures - To „D” or Not to „D”?

    Acta Endo (Buc) 2018 14(2): 235-237 doi: 10.4183/aeb.2018.235

  • Letter to the Editor

    Bothou A, Koutlaki N, Iatrakis G, Mastorakos G, Tsikouras P, Liberis V, Galazios G, Liberis A, Lykeridou A , Zervoudis S

    Antimullerian Hormone as Indicator of Ovarian Dysfunction

    Acta Endo (Buc) 2017 13(2): 237-245 doi: 10.4183/aeb.2017.237

    Abstract
    Aim. The purpose of this study was to examine various hormonal, biochemical and environmental factors (i.e., smoking and alcohol intake) and to investigate their possible correlation to the development of polycystic ovary syndrome (PCOS). The main objective was to evaluate the associations between hormonal profile and the antimüllerian hormone (AMH) levels in PCOS patients and their relation to environmental factors. Patients and Methods. In two gynecological clinics, 38 women with PCOS (defined according to the Rotterdam criteria) were enrolled and observed in relation to AMH, follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T), Δ4-androstendione (Δ4- A), dehydroepiandrosterone sulfate (DHEA-S) and glucose plasma concentrations. Obesity, smoking and alcohol exposure were also studied. Results. AMH, T, Δ4-Α, DHEA-S, LH and FSH were increased in 76.3%, 50%, 31.8%, 23.7%, 21% and 18.4% of the patients, respectively. The LH/FSH ratio and glucose concentrations increased abnormally in 18.4% and 15.8% of the patients, respectively. AMH and T levels were both increased in 47.4% of the patients whereas both AMH and LH levels increased in 21% of the patients. Smoking, alcohol intake, obesity and glucose concentrations were not associated with AMH concentrations. On the contrary, high levels of T and LH were linked to higher levels of AMH. FSH concentrations were not increased in these patients. Conclusion. AMH is an important hormonal parameter for the diagnosis of PCOS. Larger clinical controlled studies are necessary in an effort to further investigate the inclusion of AMH measurement in the diagnostic criteria of PCOS.
  • Case Report

    Ge J, Wang J, Liu H, Wan R, Yao X

    131I Successfully Treated a Case of Hyperthyroidism after Allogeneic Hematopoietic Stem Cell Transplantation

    Acta Endo (Buc) 2022 18(2): 238-240 doi: 10.4183/aeb.2022.238

    Abstract
    Hematopoietic stem cell transplantation (HSCT) is an effective treatment for various types of hereditary hematologic disease, hematological malignancy, primary immunodeficiency and metabolic disease. Thyroid dysfunction is a common complication of HSCT, which situation is mainly manifested as hypothyroidism and rarely as hyperthyroidism. This report presents a 28-yearold man who developed hyperthyroidism 9 years after sibling allogeneic HSCT, which was most likely caused by chronic GVHD. In the meantime, the patient also suffered from liver dysfunction and pancytopenia, for which he was inappropriate to take antithyroid drugs (ATD) for treatment of hyperthyroidism. The patient was orally administered 259 MBq 131I, an individualized dose. The symptoms of hyperthyroidism were mitigated by 131I treatment.